2021 IVD Market Update and COVID-19 Impact

    Published: March 12, 2021 | Price: $3,000.00 – $6,000.00

    What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...
    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)

    Published: June 25, 2025 | Price: $5,600.00 – $8,000.00

    Updated quarterly (four times a year) to reflect market changes   Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape. Leveraging over two decades of...
    30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)

    Published: October 27, 2023 | Price: $5,000.00 – $10,000.00

    In vitro diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning.  Kalorama's 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning. Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has...
    30-Country IVD Market Atlas, 2024 (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries) [December 2024 update]

    Published: December 23, 2024 | Price: $5,000.00 – $10,500.00

    Now in its fourth and final update in 2024!   What’s Included One Report Covering 30 Countries Sizing for 20 Important IVD Market Segments Segments Estimated for Each Country Forecasts to 2028 for Each Segment Updated Quarterly (4 updates annually) to Reflect Market Changes Over 2800 Data Points About the Report With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information understands the importance of global coverage and the need for more detailed geographic...
    Allergy Immunoassay Brief

    Published: September 29, 2021 | Price: $3,000.00 – $6,000.00

    Allergies are a number of conditions that are caused by hypersensitivity to a substance in the environment. Allergies can run the gamut of seasonal nuisances to life-threatening ordeals. Allergy statistics show that these conditions are constantly present in lives and are not going away. Factors contributing to allergies worldwide include: Environmental pollution Changing lifestyles and dietary patterns Indoor pollution An individual who is overly reactive to an antigen that is tolerated by most others is said to be hypersensitive (allergic). ...
    At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests)

    Published: March 29, 2022 | Price: $3,750.00 – $7,500.00

    The at-home IVD testing market is a growing market with much potential. This report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), analyzes at-home tests where the entire process is done at home. A sample is collected, and the results are provided in under one hour. This does not include self-collection at home and then sent to a laboratory where it can be analyzed. This report is segmented into three areas: Glucose Infectious disease Other...
    At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023

    Published: June 6, 2023 | Price: $5,000.00 – $10,000.00

    This new Kalorama Information report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023, examines a range of both at-home tests and home collection tests. The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods. [caption id="attachment_19849"...
    At-Home Testing: COVID-19 Trends and Future Potential

    Published: April 15, 2021 | Price: $3,000.00 – $6,000.00

    This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or...
    Autoimmune Immunoassay Brief

    Published: September 29, 2021 | Price: $3,000.00 – $6,000.00

    A considerable number of diagnostic tests are available or in development for the detection of autoimmune diseases. Because of this potentially large and growing market, vast opportunity exists for discovery and advancement in this arena. Competition within this market is expected to increase dramatically. However, in fledgling autoimmune IVD diagnostic testing markets, a golden opportunity exists to capitalize on new testing innovations without significant competition. In terms of test options, a substantial amount of overlap exists in the various autoimmune...
    COVID-19 Testing Market Update, 2022

    Published: April 19, 2022 | Price: $3,750.00 – $7,500.00

    This report, COVID-19 Testing Market Update, 2022, provides market sizing and estimates for COVID-19 tests with some discussion of market impacts of COVID-19.  The scourge of COVID-19 continued to occupy laboratories and the in vitro diagnostic (IVD) companies that serve them throughout 2021 and into 2022.  Testing already present in large labs and clinics entered the home last year, which added to market revenues. There was 33 BN of revenues in 2021, and the report details the share of antigen,...
    COVID-19 Testing Markets, 2023

    Published: April 24, 2023 | Price: $5,000.00 – $10,000.00

    Covid-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023. The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of...
    COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

    Published: November 2, 2020 | Price: $4,000.00 – $8,000.00

    COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...
    Global Digital Pathology Markets

    Published: January 21, 2022 | Price: $5,000.00 – $10,000.00

    Kalorama Information has covered digital pathology markets in line with its coverage of related in vitro diagnostic tests for over a decade.  This 2022 edition, Global Digital Pathology Markets, clarifies the market situation given recent changes due to COVID-19’s lingering presence and impact. The report provides: Market for Digital Pathology, Now and in 2026 Position of Major Players Regional Analysis Trends – Market Drivers and Limiters Trends – Artificial Intelligence (AI) Trends – Quantum Computing Scanners Market Software and Other...
    In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028

    Published: September 22, 2023 | Price: $6,000.00 – $12,000.00

    In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report...
    In Vitro Diagnostic (IVD) Trends and Market Update: December 2024

    Published: December 6, 2024 | Price: $5,000.00 – $10,500.00

    The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product developments, shifts in global health spending, regulatory changes, and disease trends, maintaining its resilience. Several segments within the IVD market are experiencing significant growth and...
    In Vitro Diagnostic (IVD) Trends and Market Update: November 2023

    Published: November 7, 2023 | Price: $3,750.00 – $7,500.00

    In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors...
    In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022

    Published: October 18, 2022 | Price: $5,000.00 – $10,000.00

    The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three...
    In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029

    Published: November 25, 2024 | Price: $5,000.00 – $10,500.00

    The U.S. IVD market is a cornerstone of global healthcare innovation—but it is also a market in transition In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, the fifth edition in Kalorama’s ongoing series, offers unparalleled access to insights on the trends and technologies that will define the industry's future. This report is essential for: Identifying market gaps and opportunities for product innovation. Gaining a competitive edge with strategic insights into the U.S. diagnostic landscape. Making informed...
    In Vitro Diagnostics (IVD) Market in China, 2021

    Published: September 29, 2021 | Price: $4,000.00 – $8,000.00

    As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)

    Published: June 24, 2025 | Price: $5,250.00 – $7,500.00

    The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions. As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater. In Vitro Diagnostics Business...
    Infectious Disease Diagnostic Testing: World Market Analysis

    Published: April 7, 2022 | Price: $6,000.00 – $12,000.00

    The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD   [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption]   Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...
    Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029

    Published: November 19, 2024 | Price: $6,300.00 – $12,600.00

    Stay Ahead of the Curve with Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029: With the global demand for infectious disease IVD products projected to surge, understanding market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern.   Abstract As infectious diseases continue to pose significant global health challenges, diagnostic testing has emerged as a vital tool...
    IVD Market Trends Report, March 2023

    Published: March 17, 2023 | Price: $3,750.00 – $7,500.00

    Diagnostic testing continues to be a valuable resource to help physicians arrive at a diagnosis. Additionally, it has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. Now, in the aftermath of the COVID-19 pandemic, new products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient. Ultimately, the...
    IVD Test Procedure Volumes, 2024-2029

    Published: October 8, 2024 | Price: $6,300.00 – $12,600.00

    Act Now – Be Prepared for Tomorrow’s IVD Market Don’t miss your chance to leverage Kalorama Information’s expert insights. Equip your business with the knowledge to anticipate changes, optimize product development, and maximize your strategies in the dynamic IVD landscape. Ready to take action? Purchase the IVD Test Procedure Volumes, 2024-2029 report today and secure your competitive advantage in this billion-dollar industry.   Abstract Kalorama Information's IVD Test Procedure Volumes, 2024-2029 report provides a deep dive into the global trends...
    IVD Trends and Market Update, March 2022

    Published: March 23, 2022 | Price: $5,000.00 – $10,000.00

    What’s Driving Growth in the IVD Market in 2022? What Major Trends are Affecting the Market in 2022? How Has COVID-19 Impacted and Continued to Impact the Market in 2022? What Product Trends and New Developments Will Shape the IVD Market in 2022? Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q1 2022. The demand for testing...
    IVD Trends and Market Update: November 2022

    Published: November 17, 2022 | Price: $5,000.00 – $10,000.00

    What’s Driving Growth in the IVD Market in Q3 and the last half of 2022? What Major Trends are Affecting the Market in Q3 and the last half of 2022? How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022? What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022? Diagnostic test products have never been more important. This report is an update of the...
    Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets

    Published: May 14, 2020 | Price: $4,000.00 – $8,000.00

    CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...
    Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas

    Published: April 7, 2020 | Price: $750.00 – $1,000.00

    For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...
    Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)

    Published: April 12, 2021 | Price: $4,000.00 – $8,000.00

    Contract manufacturing is an increasing part of the pharmaceutical business.  In cell therapy this need is magnified because of the demand for cell and gene therapy products.  Kalorama Information's report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following: Biopharmaceutical Contract Manufacturing Market Role Services Offered Usage Drivers Profiles of Companies, Key Players, and Competitors in the Market COVID-19’s Challenges and Opportunities for CMOs Global and Regional Market Overviews—U.S., Europe, and Other Nations New Developments and...
    Molecular Diagnostics Quarterly Datastream

    Published: May 5, 2022 | Price: $10,000.00

    NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests Report, World Molecular Diagnostics Report or Molecular Point-of-Care (POC) report.  All in any edition.  This is because this is a quarterly update to markets covered in these reports.     The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel...
    Molecular Diagnostics Quarterly Datastream, 2024

    Published: November 30, 2024 | Price: $10,500.00

    NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report.  All in any edition.  This is because this is a quarterly update to markets covered in these reports.   The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...
    Molecular Diagnostics Quarterly Datastream, 2025

    Published: April 2, 2025 | Price: $7,700.00 – $11,000.00

    Important Note: The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports. Stay Ahead with the Latest Information: Subscribers will receive data updates after each financial quarter for one year, totaling four updates (Q4 2024, Q1 2025, Q2 2025, Q3 2025). These updates are provided in an Excel spreadsheet, making them easily...
    Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024-2029

    Published: March 4, 2025 | Price: $5,600.00 – $8,000.00

    Molecular point-of-care (mPOC) diagnostics are revolutionizing the in vitro diagnostics (IVD) landscape, delivering the sensitivity and specificity of molecular testing with the accessibility and speed of traditional point-of-care (POC) solutions. Kalorama Information’s latest report, Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024-2029, provides a comprehensive analysis of this rapidly evolving market, covering the size, growth trajectory, and competitive dynamics forecasted over a five year span to 2029. Market Drivers & Opportunities mPOC has transitioned from an emerging innovation to a major...
    Remote Patient Monitoring and Telehealth Markets, 13th Edition

    Published: November 27, 2023 | Price: $5,000.00 – $10,000.00

    Telehealth and remote patient monitoring have become integral to improving health conditions and preventing health complications. The transformations observed during the pandemic have bolstered telemedicine and, consequently, remote patient monitoring, instilling confidence in virtual patient assessment and access to advanced technological monitoring. Since January 2019, remote patient monitoring has experienced a significant surge, and current telehealth systems are leveraging key technologies increasingly prevalent in the health industry to foster further growth. Kalorama Information analyzes these trends and more in Remote...
    Sepsis Diagnostics Products and Market Trends

    Published: October 26, 2020 | Price: $3,000.00 – $6,000.00

    The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently.  In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths.  Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.   This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...
    The Market and Future Potential for Molecular Point of Care (mPOC), 2023

    Published: February 7, 2023 | Price: $5,000.00 – $10,000.00

    This report is an essential tool for understanding the size and growth opportunity in molecular POC.  Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market.  The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market.  Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...
    The Market for In Vitro Diagnostic (IVD) Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and Other Nations)

    Published: January 23, 2023 | Price: $5,000.00 – $10,000.00

    This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region. Combined, these...
    The Market for Molecular Point-of-Care (mPOC), 2024

    Published: March 7, 2024 | Price: $5,000.00 – $10,500.00

    Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...
    The World Market for Molecular Diagnostics, 12th Edition

    Published: December 19, 2023 | Price: $3,750.00 – $7,500.00

    Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...
    The World Market for Molecular Diagnostics, 13th Edition

    Published: December 19, 2024 | Price: $3,950.00 – $7,875.00

    The molecular diagnostics market, a driving force within the global in vitro diagnostics (IVD) industry, continues to thrive several years post-pandemic, offering significant growth opportunities across infectious diseases, cancer, and transplant diagnostics. Kalorama Information's latest report, The World Market for Molecular Diagnostics, 13th Edition, provides an unparalleled deep dive into this dynamic sector, revealing key trends, applications, and innovations shaping the market from 2024 to 2029. Why This Report is a Must-Have: Comprehensive Market Insights: Analyze global and regional molecular...
    The World Market for Vaccines, 2022-2027

    Published: September 23, 2022 | Price: $5,000.00 – $10,000.00

     V A C C I N E  M A R K E T  E X C E E D S $200 B I L L I O N In 2022, the global market for preventive vaccines is valued at $202.6 billion.  That's up from $34.1 billion in 2017, and just $25 billion in 2010.  Infectious diseases are some of the deadliest diseases that pose significant risk to human life. Sales increased from $127.6 billion in 2021 to $202.6 billion in...
    The World Market for Vaccines, 2024

    Published: February 22, 2024 | Price: $5,000.00 – $10,500.00

    Vaccines offer long-term or permanent immunity against diseases. They have been a cornerstone of preventive medicine for over 70 years, stimulating an immune response to specific diseases. The widespread adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related deaths are now rare in developed nations and decreasing globally. Smallpox has been eradicated, polio eliminated...
    The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition

    Published: August 29, 2024 | Price: $8,750.00 – $17,500.00

    Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2024 to 2029, and essential insights needed to understand the IVD market in its entirety. With every significant test category covered in detail, it's like having ten market research reports in one comprehensive volume. Key Features: Extensive Coverage: Detailed estimates and...
    The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

    Published: August 24, 2023 | Price: $8,750.00 – $17,500.00

    "The most trusted and essential report on the global IVD industry."   For Two Decades, One Volume Has Offered Complete Coverage of the IVD Industry The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry.  Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic...
    The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition

    Published: April 13, 2023 | Price: $6,000.00 – $12,000.00

    The point-of-care diagnostics market has long been the opportunity market within IVD.  Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters.  While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always been seen as the growth area.  There are more companies in the point of care market, and it is a top segment of investment. Now...